REDWOOD BIOSCIENCE

redwood-bioscience-logo

Redwood Bioscience is utilizing precision protein-chemical engineering to develop optimized and novel biotherapeutics. The Company's site-specific modification technology overcomes the significant challenges associated with conjugating biologics to synthetic molecules to create homogenous hybrid biotherapeutics It was founded in 2008 and headquartered in Emeryville, California.

#People #Financial #Website #More

REDWOOD BIOSCIENCE

Social Links:

Industry:
Biotechnology Chemical Health Care

Founded:
2008-01-01

Address:
Emeryville, California, United States

Country:
United States

Website Url:
http://www.redwoodbioscience.com

Total Employee:
5001+

Status:
Closed

Contact:
5102253949

Email Addresses:
[email protected]

Total Funding:
12.86 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress IPv6 Contact Form 7


Founder


carolyn-bertozzi_image

Carolyn Bertozzi

david-rabuka_image

David Rabuka

Investors List

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Venture Round - Redwood Bioscience

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - Redwood Bioscience

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Venture Round - Redwood Bioscience

mission-bay-capital-llc_image

Mission Bay Capital

Mission Bay Capital investment in Seed Round - Redwood Bioscience

Official Site Inspections

http://www.redwoodbioscience.com

  • Host name: 163.171.242.14
  • IP address: 163.171.242.14
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Redwood Bioscience"

Catalent Acquires Redwood Bioscience Inc. and SMARTagโ„ข

Oct 2, 2014ย ยท Catalent today announced that it has acquired the remaining stake in Redwood and the SMARTag Antibody-Drug Conjugate technology platform.See details»

Redwood Bioscience Inc. | Intellectual Property & Industry โ€ฆ

Redwood Bioscience, Inc. develops a protein-chemical engineering technology to produce antibody-drug conjugates and other semi-synthetic biotherapeutics.See details»

Redwood Bioscience - Crunchbase Company Profile

Contact Email [email protected] Phone Number 5102253949 Redwood Bioscience is utilizing precision protein-chemical engineering to develop optimized and novel biotherapeutics.See details»

Biosciences โ€“ E. coli recombinant proteins

Cloning, expression and characterization of recombinant CagA protein of Helicobacter pylori utilizing monoclonal antibodies: Its potential in diagnostics Helicobacter pylori CagA protein โ€ฆSee details»

Catalent Acquires Redwood Bioscience and the SMARTag โ€ฆ

Oct 2, 2014ย ยท Catalent Pharma Solutions has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology platform.See details»

Redwood Bioscience Company Profile 2024: Valuation, โ€ฆ

Developer of protein-chemical engineering technology designed to produce antibody-drug conjugates and other semi-synthetic biotherapeutics. The company's methods for drug conjugate optimization combine the binding โ€ฆSee details»

Redwood Bioscience - Overview, News & Similar companies

Redwood Bioscience contact info: Phone number: (510) 343-6031 Website: www.redwoodbioscience.com What does Redwood Bioscience do? Redwood Bioscience is โ€ฆSee details»

Catalent Expands its Technology Offerings in Biologics

Oct 10, 2014ย ยท Catalent Pharma Solutions has announced that it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology โ€ฆSee details»

Redwood Bioscience - VentureRadar

Website: http://www.redwoodbioscience.com. Redwood Biocience has a means of site specific protein modification technology that enables it to control the toxin location and stoichiometry of โ€ฆSee details»

REDWOOD BIOSCIENCE, INC. | SBIR.gov

This Small Business Innovation Research (SBIR) II project outlines in vivo testing of semi-synthetic therapeutic protein conjugates. Low molecular weight peptide drugs have had limited โ€ฆSee details»

Redwood Bioscience - Products, Competitors, Financials, โ€ฆ

Redwood Bioscience is developing SMARTag technology, a precision-protein chemical engineering platform, to produce the next generation of antibody-drug conjugates and other โ€ฆSee details»

David Rabuka Ph.D Profile: Contact Information & Network

Dr. David Rabuka is the Founder, President & Chief Scientific Officer of Redwood Bioscience. Rabuka received a Ph.D. in Chemistry at the University of California, Berkeley as a Chevron โ€ฆSee details»

Catalent Increases Stake In Redwood Bioscience | Fierce Biotech

Mar 31, 2014ย ยท Redwood Bioscience is developing a precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi โ€ฆSee details»

Q&A: David Rabuka | Research Communities by Springer Nature

David is the founder and chief scientific officer of Redwood Bioscience, a startup company focused on antibody-drug conjugates and other semi-synthetic therapeutics. David started the โ€ฆSee details»

Catalent Biologics Expands into ADCs Through Exclusive License โ€ฆ

Apr 10, 2013ย ยท SOMERSET, N.J.--Catalent Pharma Solutions today announced that it has acquired an exclusive license to market Redwood Bioscience's proprietary SMARTag โ„ข โ€ฆSee details»

Redwood Bioscience | VentureRadar

Website: http://www.redwoodbioscience.com. Redwood Biocience has a means of site specific protein modification technology that enables it to control the toxin location and stoichiometry of โ€ฆSee details»

Redwood Bioscience - CB Insights

Explore {Redwood Bioscience's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Redwood Bioscience Secures Funding for Optimized Conjugate โ€ฆ

BURLINGAME, Calif., June 27, 2011 /PRNewswire/ -- Redwood Bioscience, Inc. announced today that it has secured funding from Takeda Ventures, Inc. ("TVI") to further develop the โ€ฆSee details»

Generating Site-Specifically Modified Proteins via a Versatile and ...

To address this need, we are pioneering site-specific bioconjugation methods that use formylgly-cine as a bioorthogonal handle on a protein surface. Here we introduce aldehyde-specific โ€ฆSee details»

Redwood Bioscience | VentureRadar

Website: http://www.redwoodbioscience.com. Redwood Biocience has a means of site specific protein modification technology that enables it to control the toxin location and stoichiometry of โ€ฆSee details»

linkstock.net © 2022. All rights reserved